Trademark Overview
On Wednesday, December 18, 2024, a trademark application was filed for INSITRO with the United States Patent and Trademark Office. The USPTO has given the INSITRO trademark a serial number of 98910311. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, December 18, 2024. This trademark is owned by Insitro, Inc.. The INSITRO trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Laboratory automation systems and hardware for scientific research, drug discovery, and drug development; optical screening devices; cell imaging instruments; DNA sequencing machines; robotic laboratory systems; biosensors; high-throughput screening devices; laboratory instruments for measuring, analyzing, and monitoring biological and chemical samples; AI-powered hardware and software for scientific and laboratory applications, including experimental data generation; devices for sale or licensing to research organizations and pharmaceutical companies.
Pharmaceutical preparations and substances for human and veterinary use for the treatment and prevention of diseases; biological and chemical preparations for medical and therapeutic use; diagnostic reagents and testing kits for medical purposes; nucleic acid-based therapeutics, small molecule drugs, and biologics; pharmaceutical products informed by predictive modeling and data analysis using machine learning and artificial intelligence; precision medicine drug delivery formulations; pharmaceutical drugs; drugs for medical purposes; medicines for human purposes.
Chemical and biological reagents for scientific research, drug discovery, and drug development; sequencing reagents; optical screening reagents; cell imaging reagents; biochemical assay kits for laboratory use; reagents for laboratory automation systems and scientific apparatus; chemical preparations for high-throughput screening; laboratory chemicals and solutions for research purposes, excluding those for medical use, including reagents supporting artificial intelligence-driven workflows and machine learning applications.
Medical research and consulting services; personalized medicine services, including diagnostic and therapeutic recommendations; healthcare services utilizing artificial intelligence for disease prediction, patient stratification, and management; drug discovery and development support services from a medical perspective; medical analysis services for diagnostic and treatment purposes; providing medical information and consultancy related to therapeutic research and development; clinical trial support and patient stratification services informed by computational biology; digital health solutions integrating data-driven medical insights. medical services; health consultancy; healthcare services; medical treatment services for diseases; healthcare advisory services; collation of information in the healthcare sector, namely, the development and collation of disease knowledge data sets; pharmaceutical advice; medical clinic services; medical advice for individuals with diseases; advisory ser...
Scientific and technological research and development services in the fields of drug discovery, pharmaceutical development, and biotechnology; providing artificial intelligence (AI) and machine learning (ML) platforms for scientific and medical research; development of computer software and computational tools for drug discovery, genomics, and data analysis; laboratory research services using automation, high-throughput experimentation, and data modeling; software as a service (SaaS) featuring AI-powered drug discovery, predictive modeling, and biological data analysis; development of proprietary algorithms for scientific and medical research; multi-omics data integration services for therapeutic discovery; consulting services in computational biology and AI-driven drug discovery.
